Cart summary

You have no items in your shopping cart.

SRI 31215

SKU: orb1220935

Description

SRI 31215 a small molecule that acts as a triplex inhibitor of matriptase hepsin and HGFA and mimics the activity of HAI-1/2 endogenous inhibitors of HGF activation with IC50s of 0.69 μM 0.65 μM 0.3 μM.

Images & Validation

Key Properties

CAS Number1832686-44-8
MW533.6
Purity>98% (HPLC)
FormulaC27H34F3N5O3
TargetHGFA|matriptase|hepsin

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
DisclaimerFor research use only

Similar Products

  • SRI 31215 TFA [orb1301758]

    99.36%

    1832686-44-8

    533.6

    C27H34F3N5O3

    5 mg, 200 mg, 100 mg, 10 mg, 25 mg, 50 mg, 1 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

SRI 31215 (orb1220935)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 150.00
5 mg
$ 220.00
10 mg
$ 320.00
25 mg
$ 620.00
50 mg
$ 910.00
100 mg
$ 1,280.00